Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 7;290(32):19478-88.
doi: 10.1074/jbc.R115.662759. Epub 2015 Jun 22.

Novel Allosteric Modulators of G Protein-coupled Receptors

Patrick R Gentry  1 , Patrick M Sexton  1 , Arthur Christopoulos  2
Affiliations
Review

Novel Allosteric Modulators of G Protein-coupled Receptors

Patrick R Gentry et al. J Biol Chem. .

Abstract

G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topographically distinct, yet conformationally linked, domains. Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chemical probes due to the potential for novel therapeutics. It is now apparent that some GPCRs possess more than one targetable allosteric site, in addition to a growing list of putative endogenous modulators. Advances in structural biology are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biological characterization.

Keywords: G protein; G protein-coupled receptor (GPCR); allosteric regulation; biased agonism; bitopic ligand; chemical biology; drug discovery; structural biology.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Potential allosteric ligand-binding regions on GPCRs; some representative allosteric modulators recognizing each region are also listed. RAMP, receptor activity-modifying protein; MRAP, melanocortin receptor accessory protein; Cmpd, compound; AZ, AstraZeneca; Fz4, frizzled4 receptor; CaSR, calcium-sensing receptor; PCEP, 3-amino-3-carboxypropyl-2′-carboxyethyl phosphinic acid.
FIGURE 2.
FIGURE 2.
Timeline of representative GPCR crystal structures, 2000–2015. N/OFQ, nociception/orphanin FQ receptor; SMO, Smoothened receptor; OR, opioid receptor; H1, histamine H1 receptor; S1P1, sphingosine-1-phosphate 1 receptor.
See this image and copyright information in PMC

References

    1. Fredriksson R., Lagerström M. C., Lundin L.-G., Schiöth H. B. (2003) The G-protein-coupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256–1272 - PubMed
    1. Kenakin T., Miller L. J. (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265–304 - PMC - PubMed
    1. Oldham W. M., Hamm H. E. (2006) Structural basis of function in heterotrimeric G proteins. Q. Rev. Biophys. 39, 117–166 - PubMed
    1. Rask-Andersen M., Almén M. S., Schiöth H. B. (2011) Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 10, 579–590 - PubMed
    1. Conn P. J., Lindsley C. W., Meiler J., Niswender C. M. (2014) Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Nat. Rev. Drug Discov. 13, 692–708 - PMC - PubMed

MeSH terms

LinkOut - more resources